Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand

被引:18
作者
Chunsuttiwat, S
Biggs, BA [1 ]
Maynard, JE
Thammapormpilas, P
O-Prasertsawat, M
机构
[1] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia
[2] Minist Publ Hlth, Dept Communicable Dis Control, Nonthaburi 11000, Thailand
[3] Burnet Inst, Ctr Int Hlth, Prahran, Vic, Australia
[4] Program Appropriate Technol Hlth, Childrens Vaccine Program, Seattle, WA USA
[5] Minist Publ Hlth, Div Epidemiol, Bangkok, Thailand
[6] Sawanpracharak Hosp, Nakornsawan, Thailand
关键词
DTP-HB vaccine; hepatitis B; Thailand;
D O I
10.1016/S0264-410X(02)00461-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Combined vaccines have been advocated as an efficient method of paediatric vaccine delivery. This study examined the performance and cost implications for the use of combined DTP-HB vaccine in the Thai immumisation program. Separate DTP and HB and then combined DTP-HB vaccines were used in the infant immunisation program in Chiangrai Province during a 4-year period. DTP vaccination coverage was maintained with the combined vaccine and HB coverage was improved (95.7% for DTP-HB 1, 95.2% for DTP-HB2 and 93.8% for DTP-HB3). Seroconversion rates for anti-HBs rose from a baseline of 88.4 to 94.8% with use of the combined vaccine. Seroconversion rates for anti-D (97.5%) and anti-P (89.6%) were higher in the separate vaccine regimen. Although this study was not able to demonstrate that DTP-HB vaccine was more cost saving than the vaccines given separately as baseline vaccine coverage was already high, in settings where coverage rates are much lower the increased cost of combined vaccines may be more justifiable. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 13 条
[1]   Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines:: A comparison of two doses (10 μg and 5 μg) [J].
Chiu, HH ;
Huang, LM ;
Lee, PI ;
Safary, A ;
Lee, CY .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) :206-211
[2]   Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand [J].
Chunsuttiwat, S ;
Biggs, BA ;
Maynard, J ;
Thamapalo, S ;
Laoboripat, S ;
Bovornsin, S ;
Charanasri, U ;
Pinyowiwat, W ;
Kunasol, P .
VACCINE, 1997, 15 (6-7) :769-774
[3]   Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants [J].
DiezDelgado, J ;
DalRe, R ;
Llorente, M ;
Gonzalez, A ;
Lopez, J .
VACCINE, 1997, 15 (12-13) :1418-1422
[4]  
*GLOB ALL VACC IMM, SUMM AW 36 COUNTR GA
[5]  
JACOBS L, 2000, IMMUNIZATION FOCUS
[6]   Status of hepatitis B immunization programmes in 1998 [J].
Kane, MA .
VACCINE, 1998, 16 :S104-S108
[7]  
*MIN PUBL HLTH, 1999, EPI COV SURV
[8]   Current combined vaccines with hepatitis B [J].
Papaevangelou, G .
VACCINE, 1998, 16 :S69-S72
[9]   EVALUATION OF A COMBINED TETRAVALENT DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS AND HEPATITIS-B CANDIDATE VACCINE ADMINISTERED TO HEALTHY INFANTS ACCORDING TO A 3-DOSE VACCINATION SCHEDULE [J].
PAPAEVANGELOU, G ;
KARVELIS, E ;
ALEXIOU, D ;
KIOSSOGLOU, K ;
ROUMELIOTOU, A ;
SAFARY, A ;
COLLARD, F ;
VANDEPAPELIERE, P .
VACCINE, 1995, 13 (02) :175-178
[10]  
POORVORAWAN Y, 1997, ANN TROP PAEDIATR, V17, P301